Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-06-19, Stock:LLY, The news for the past five days is as follows:
2018-06-12: NEWS1: Eli Lilly, AstraZeneca Shares Fall After Halting Alzheimer's Drug Test.NEWS2: AstraZeneca, Lilly Join Others On Failed Alzheimer&apos;s Drug Heap.NEWS3: AstraZeneca, Lilly halt tests of experimental Alzheimer&apos;s treatment.NEWS4: Eli Lilly, Electronic Arts, PayPal, Palo Alto Networks & ....NEWS5: Allergan's Second Anti-CGRP Drug Positive in Mid-Stage Study.NEWS6: Allergan's Second Anti-CGRP Drug Positive in Mid-Stage Study.NEWS7: Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate.NEWS8: Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate.NEWS9: Alzheimer's Research Stumbles Again: What's the Road Ahead?.NEWS10: Alzheimer's Research Stumbles Again: What's the Road Ahead?.NEWS11: Lilly & AstraZeneca Scrap Studies on Alzheimer&apos;s Candidate.NEWS12: Alzheimer&apos;s Research Stumbles Again: What&apos;s the Road Ahead?.NEWS13: Lilly-AstraZeneca latest to abandon Alzheimer's drug trials.NEWS14: Another Alzheimer's Drug Fails as Lilly, Astra Halt Tests.NEWS15: Another Alzheimer's Drug Fails as Lilly, Astra Halt Tests.NEWS16: Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease.NEWS17: [$$] AstraZeneca and Eli Lilly scrap Alzheimer’s drug trial.NEWS18: AstraZeneca, Eli Lilly To Discontinue Lanabecestat Trials In Alzheimer's.NEWS19: AstraZeneca, Eli Lilly To Discontinue Lanabecestat Trials In Alzheimer's.
2018-06-13: NEWS1: Lilly's lupus treatment succeeds in mid-stage trial.NEWS2: Lilly's lupus treatment succeeds in mid-stage trial.NEWS3: J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit.NEWS4: J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit.NEWS5: J&J (JNJ) Accepts Platinum Equity&apos;s Offer for LifeScan Unit.NEWS6: [$$] Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer’s Drug Trials.NEWS7: CAH Closer To FDA Approval, Another Alzheimer's Disease Drug Fails, VTVT Tanks.NEWS8: CAH Closer To FDA Approval, Another Alzheimer's Disease Drug Fails, VTVT Tanks.
2018-06-14: NEWS1: Eli Lilly CEO: 'It's time for a change' in the drug pricing system.NEWS2: Should You Be Tempted To Sell Eli Lilly and Company (NYSE:LLY) Because Of Its PE Ratio?.NEWS3: Eli Lilly CEO: 'It's time for a change' in the drug prici....NEWS4: Allergan (AGN) Presents Positive Data on Glaucoma Candidate.NEWS5: Allergan (AGN) Presents Positive Data on Glaucoma Candidate.NEWS6: Merck's Keytruda Gets FDA Nod for 2nd Lymphoma Indication.NEWS7: Merck's Keytruda Gets FDA Nod for 2nd Lymphoma Indication.NEWS8: This Day That Year: Athenex.NEWS9: This Day That Year: Athenex.
2018-06-15: NEWS1: Teva Scraps A Study In Cluster Headaches — And This Rival Benefits.NEWS2: Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals.NEWS3: Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals.NEWS4: Pharma Stock Roundup: LLY/AZN Alzheimer&apos;s Drug Fails, MRK&apos;s Keytruda Wins Approvals.
2018-06-18: NEWS1: Lilly Declares Third-Quarter 2018 Dividend.NEWS2: Large Cap Pharma Stock Outlook: Short-Term Struggle Likely.NEWS3: Large Cap Pharma Stock Outlook: Short-Term Struggle Likely.NEWS4: Large Cap Pharma Stock Outlook: Short-Term Struggle Likely.

Answer: Rise